Corona Vaccine Sputnik V trial in India

Corona Vaccine Sputnik V trial in India

Posted on

Russia’s ‘Sputnik V’ was registered as the world’s first corona antidote on 11th August.

Many countries are trying to get this Russia, that is the demand of Domitrev.

The head of the country’s direct investment fund. Russian Health Minister Mikhai Murasko has said that the first batch of Sputnik V will arrive in 15 days.

On Wednesday (12th August), the Russian government direct investment fund (RDIF) claimed on its official website that at least 20 countries had expressed interest in getting Sputnik V.

Corona Vaccine Sputnik V trial in India

Trials and subsequent trials of this antidote will begin in these countries. The list also includes Turkey, Cuba, South Korea, Brazil or India.

The antidote was developed by the Microbiology in Russia and the Gamalei Institute of Epidemiology.

Russian Health Minister Mikhail Murshko said a vaccination order had already been issued next month. Vaccine production is in full swing.

Russia will be able to produce more than 45 million doses of antidote in this year.

However, the third phase of the trial will continue along with the production of the antidote in India.

Russia, however, claimed that India was also a partner in the production and trial of the Sputnik V after the registration of the antidote.

Read more a – Solar storms can disrupt the earth’s wireless connection!

Russia’s health ministry has denied the allegations in a statement issued Friday stating Similar.

Baseless allegations concerning Russia’s intelligence have been made more than once.

Officials at the Union Ministry of Health claim that there has been no official discussion between the two countries about the production of the Russian antidote and the trial partnership.

Health ministry officials claim that any trial requires permission from the Drug Controller General of India (DCGI).

Russia has not yet taken any action in this regard trail start soon in India.

Leave a Reply

Your email address will not be published. Required fields are marked *